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Abstract 
IgA nephropathy (IgAN) is the commonest primary glomerular disease worldwide. Studies on its prevalence in Brazil 
are however scarce. Databases and clinical records from 10 reference centres were retrospectively reviewed. Clini‑
cal and laboratory features at the moment of the biopsy were retrieved (age, gender, presence of hematuria, serum 
creatinine [mg/dL], proteinuria [g/24 h]). Renal biopsy findings were classified according to Haas single grade clas‑
sification scheme and the Oxford Classification of IgAN. 600 cases of IgAN were identified, of which 568 (94.7 %) were 
on native kidneys. Male to female ratio was 1.24:1. Patients averaged 32.76 ± 15.12 years old (range 4–89, median 32). 
Proteinuria and hematuria were observed, respectively in 56.63 and 72.29 % of patients. The association of both these 
findings occurred in 37.95 % of the cases. Serum creatinine averaged 1.65 ± 0.67 mg/dL (median 1.5 mg/dL) at diag‑
nosis. Segmental sclerosis and mesangial hypercellularity were the main glomerular findings (47.6 and 46.2 %) The 
commonest combination by Oxford Classification of IgAN, was M0 E0 S0 T0 (22.4 %). Chronic tubulo‑interstitial lesions 
with an extension wider than 25 % of the renal cortex could be identified in 32.2 % of the cases. Tubular atrophy and 
interstitial fibrosis were more strongly associated with higher 24‑h proteinuria and serum creatinine levels. Segmental 
sclerosis (S1) showed a stronger tendency of association with the presence of tubulo‑interstitial lesions (T1 and T2) 
than other glomerular variables. To the best of our knowledge this is the largest series of IgAN in Brazil. It depicts the 
main biopsy findings and their possible clinical correlates. Our set of data is comparable to previous reports.
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Background
IgA nephropathy (IgAN) is the primary glomerular dis-
ease with the highest prevalence in the world (Roberts 
2014; Wyatt and Julian 2013). From the pathologist’s 
viewpoint, the diagnosis of IgAN is relatively straightfor-
ward, through the identification of dominant or codomi-
nant immunoglobulin A (IgA) deposits of mesangial and, 
to a lesser degree, capillary wall location by immunofluo-
rescence or immunoperoxidase techniques. Despite the 
relative objectivity of the immunofluorescence/immun-
operoxidase diagnostic criteria, light microscopy changes 
tend to be variable, ranging from normality to severe 
proliferative and chronic scleroatrophic lesions, which 
reflect the diversity of the clinical picture of the disease 
(Roberts 2014; Wyatt and Julian 2013; Haas 2007; Hen-
nigar and Tumlin 2009). From the clinician viewpoint, a 
number of clinical and laboratory parameters have been 
correlated with worse clinical outcomes, such as the rise 
of serum activated C3, elevated urinary interleukin-6 
(IL-6) level and the increased relation of urinary IL-6 
and epidermal growth factor (EGF) (Zwirner et al. 1997; 
Ranieri et  al. 1996). In clinical practice, however, usual 
prognostic factors in IgAN are glomerular filtration rate, 
serum creatinine value and 24-h proteinuria (Barratt and 
Feehally 2011).
IgAN is regarded as the commonest primary glomeru-
lonephritis in most developed countries (Roberts 2014; 
Wyatt and Julian 2013). The male to female ratio is 2:1 
in North American and Western European cohorts, 
with a peak incidence in the second and third decades 
of life (Wyatt and Julian 2013). A higher frequency of 
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the disease is observed among Asian populations, but 
this finding may reflect different biopsy recommenda-
tions and screening policies (Roberts 2014). Figures on 
the prevalence and impact of IgAN in Brazil are however 
scarce. A recent paper regarding 9617 countrywide renal 
biopsies depicted a 9.6 % and a 20.1 % incidence among 
all and among primary glomerulopathies, respectively 
(Polito et al. 2009). IgAN accounts for varying ranges of 
1–10.7 % of all glomerulopathies and 2–25 % of primary 
glomerulopathies according to other local reports (Fer-
raz 2010; Queiroz 2009; Cardozo and Kirsztajn 2006). 
Besides, data on the correlation of histopathological find-
ings to clinical outcome are lacking in our country.
Methods
This study was conducted under the auspices of the Kid-
ney Club of the Brazilian Society of Pathology. Twelve 
renal pathologists pertaining to ten institutions contrib-
uted with data (UNIFESP, 108 cases; UFPR, 44 cases; 
UFF, 36 cases; UFOP and UFMG, 55 cases; Ana Costa 
Hospital, 9 cases; UNICAMP, 241 cases; CPqGM-
FIOCRUZ, 17 cases; UFMA, 26 cases; Santa Casa de 
Misericordia de Porto Alegre, 64 cases).
Renal tissue was obtained by biopsy and processed for 
light microscopy, immunofluorescence microscopy, with 
a panel of anti-human antibodies directed towards IgA, 
IgG, IgM, C3, C1q and kappa and lambda light chains, 
and electron microscopy when available. IgAN was 
defined as the finding of consistent dominant granular to 
globular IgA deposits in mesangial areas and less promi-
nently along capillary walls or codominant deposits with 
the same distribution pattern alongside milder C3 or IgG 
deposits. Light microscopy findings were classified by 
Haas single grade classification scheme (Haas 2007) and 
by Oxford Classification of IgAN (Working Group of the 
International IgA Nephropathy Network and the Renal 
Pathology Society et  al. 2009a, b). Clinical data—24  h 
proteinuria, serum creatinine and main clinical features 
at the moment of the biopsy were collected from clinical 
reports when available. Descriptive statistical data were 
expressed as means and standard deviations. Inferential 
statistics was performed through Wilcoxon rank sum test 
with continuity correction, Kruskal–Wallis rank sum test 
and Fisher’s exact test.
Results
Six hundred (600) consecutive cases were identi-
fied from 2006 to 2013 in ten Brazilian reference cen-
tres of which 568 (94.7  %) were reported on native 
kidneys and 32 (5.3  %) were reported on transplanted 
kidneys. Male to female ratio was 1.24:1. Patients aver-
aged 32.67  ±  15.12  years old (range 4–89; median 32). 
Hematuria was present in 56.63  % of patients, which 
was isolated in 27.66 % of these patients. Proteinuria was 
observed in 72.29  % of patients, which was within the 
nephrotic range in 28  % of these. Frank nephrotic syn-
drome was observed in 21  % of the patients with pro-
teinuria. Overlapping proteinuria and hematuria was 
observed in 37.95  % of the patients in the cohort. Pro-
teinuria levels averaged 3.27 ± 3.13 g/24 h (range 0.19–
12; median 2.0). Average serum creatine value at biopsy 
was of 1.65 ± 0.67 mg/dL (range 0.8–3.75; median 1.5). 
Other presentations included rapidly progressive glomer-
ulonephritis (2.4 %) and nephritic syndrome (1.2 %).
Regarding pathological features, all cases (100  %) 
depicted diffuse and dominant mesangial IgA depos-
its with moderate to absent concurrent C3 deposits at 
immunofluorescence microscopy, in keeping with the 
diagnosis of IgAN. In 300 cases (50 %) electron micros-
copy was available and revealed variable mesangial 
to paramesangial electrondense deposits. 508 cases 
(85.23  %) showed signs of glomerular lesions at light 
microscopy. Segmental sclerosis (Haas class II, Oxford 
S1), mesangial hypercellularity (Haas class I, Oxford 
M1) and endocapillary proliferation (Haas classes III 
and IV, Oxford E1) were observed, respectively in 47.6, 
42.2 and 13.7 % of the patients. Crescents were identified 
in 13.2 % of the cases of which 70.9 % were cellular and 
29.1 % fibrocellular. Signs of advanced sclerosing glomer-
ulonephritis (Haas class V) were present at diagnosis in 
10.7  % of the patients. Glomerular lesions could not be 
adequately classified in 3 of the 346 cases (0.87  %) due 
to superimposed lesions of diabetic nephropathy. None 
of the transplanted kidneys depicted signs of transplant 
glomerulopathy.
Absent to mild tubular atrophy and interstitial fibrosis 
(Oxford T0) was identified in 67.8 % of the cases. Moder-
ate (Oxford T1) and severe (Oxford T2) tubular atrophy 
and interstitial fibrosis were present at diagnosis in 20.7 
and 11.5 % of the cases. Overall, the most prevalent pat-
tern association according to the Oxford Classification 
was M0 E0 S0 T0 (22.4 %).
Wilcoxon rank sum test and Kruskal–Wallis rank sum 
test were performed to test if any of the Oxford classifica-
tion variables were more strongly associated with labora-
tory data. A trend towards higher 24-h proteinuria levels 
was observed in patients whose biopsies revealed mesan-
gial hypercellularity (Oxford M0  =  2.35  ±  2.08  g/24  h 
vs. Oxford M1  =  3.51  ±  2.99  g/24  h; P  =  0.06). The 
presence of moderate tubular atrophy and interstitial 
fibrosis was associated with higher levels of 24-h pro-
teinuria (Oxford T0  =  2.14  ±  1.85  g/24  h vs. Oxford 
T1  =  3.09  ±  2.66  g/24  h; P  <  0.001). However, no sig-
nificant differences were found regarding 24-h pro-
teinuria levels when comparing Oxford T0 and T2 
(3.02  ±  2.07  g/24  h) or Oxford T1 with T2 (P  =  0.22 
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and 0.20) (Fig.  1). Regarding serum creatinine levels 
the more extensive the tubular atrophy and interstitial 
fibrosis the higher the serum creatinine levels (Oxford 
T0 = 1.45 ± 0.67 mg/dL; Oxford T1 = 1.61 ± 0.72 mg/
dL; Oxford T2 = 3.55 ± 1.98 mg/dL; T0 vs. T2 P < 0.001; 
T1 vs. T2 P  =  0.04). However patients with moder-
ate tubular atrophy and interstitial fibrosis did not 
show higher serum creatinine levels when compared to 
patients with none to mild changes (Oxford T1 vs. T0, 
P =  0.13) (Fig.  2). The abovementioned results indicate 
that tubulo-interstitial but not glomerular variables were 
associated with worst laboratory parameters—24-h pro-
teinuria and higher serum creatinine levels. We found 
out that when all glomerular variables equaled zero (M0, 
E0 and S0), T equaled zero (T0) in a significantly higher 
frequency than that of T1 or T2 cases (22.38 vs. 6.39 %, 
P  =  4.475e−09). Thus, to test if any single glomerular 
variable was more frequently associated with the pres-
ence of chronic tubulo-interstitial lesions (T  ≠  0) we 
carried out Fisher’s exact test. None of the glomerular 
variables was more frequently associated to the presence 
of tubular atrophy and interstitial fibrosis (Oxford T1 and 
T2). However upon the presence of segmental sclerosis 
(S1) there was a slight trend towards a higher frequency 
of T1 and T2 lesions (M0 E0 S1 T0 = 14.8 %; M0 E0 S1 
T ≠ 0 = 7.8 %; P = 0.09). This trend could not be proved 
for M1 and E1 lesions (M1 E0 S0 T0 = 11.9 %; M1 E0 S0 
T ≠ 0 = 3.8 %; P = 0.84/M0 E1 S0 T0 = 0.9 %; M0 E1 S0 
T ≠ 0 = 0.9 %; P = 0.15). These figures are summarised 
on Table 1.
Discussion
This study presents the largest IgAN cohort to date in 
this particular South American country. It encompasses 
kidney samples obtained in 10 reference institutions 
located on the three most densely populated and ethni-
cally diverse areas of the country (Northeast, 2 centres, 
34 cases; Southeast, 6 centres, 458 cases; South, 2 cen-
tres, 108 cases). IgAN patients from—have a slight male 
predominance (55.4  %) as opposed to the Oxford Clas-
sification original cohort (72  %) (Working Group of the 
International IgA Nephropathy Network and the Renal 
Pathology Society et  al. 2009a; b) and North American 
data (64  %) (Wyatt and Julian 2013) but in accordance 
with a Chinese (50 %) (Zeng et al. 2012) and a previous 
national cohort (53.7 %) (Neves et al. 2012). Patients were 
diagnosed with IgAN at the average age of 32.67 years old 
similarly as other reported series including the Oxford 
Fig. 1 24‑h proteinuria (g/24 h) values according to Oxford classification. M mesangial hypercellularity (0 absent; 1 present); E endocapillary 
proliferation (0 absent; 1 present); S segmental sclerosis/adhesions/synechiae (0 absent; 1 present); T tubular atrophy/interstitial fibrosis (0–0–25 %; 
1–26–50 %; 2 to >50 %)
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Classification cohort (Working Group of the Interna-
tional IgA Nephropathy Network and the Renal Pathol-
ogy Society et  al. 2009b; Zeng et  al. 2012). Reported 
incidence of hematuria (56.63  %) is in dissonance with 
a large recent Chinese series (27  %) (Zeng et  al. 2012). 
However Wyatt and Julian (2013) reported hematuria 
during upper respiratory tract or gastrointestinal tract 
disease in 75 % of the North American patients. In this 
cohort patients presented at diagnosis with average 24-h 
proteinuria levels near the nephrotic range (3.27 g/24 h), 
higher than previous reports (Zeng et  al.  =  1.3  g; 
Oxford  =  1.7  g; Neves  =  1.8  g; Moriyama  =  1.19  g) 
(Working Group of the International IgA Nephropathy 
Network and the Renal Pathology Society et al. 2009a, b; 
Zeng et al. 2012; Neves et al. 2012; Moriyama et al. 2014) 
but comparable to the data by Huerta et al. (2011) (3.7 g). 
However the higher levels of proteinuria in our series and 
the frequency of nephrotic syndrome as initial presenta-
tion could be a result of biopsy indication bias. Unfortu-
nately, none of the included cases with massive, nephrotic 
range proteinuria, underwent ultrastructural studies and 
superimposed podocytopathy/minimal change disease 
could not be ruled out. 24-h proteinuria might thus be 
not completely attributable to IgAN in these particular 
cases.
The importance of proteinuria as a predictor of 
decreasing estimated glomerular filtration rate (eGFR) 
was highlighted by previous studies (Moriyama et  al. 
2014; Bartosik et al. 2001; Barbour and Reich 2012). Thus 
maintenance of 24-h proteinuria levels below 1 g/24 h is 
one of the targets in the management of IgAN. Recognis-
ing which pathological variables are associated with ensu-
ing proteinuria is hence a useful piece of information. 
The original Oxford Classification cohort demonstrated 
that mesangial hypercellularity, segmental sclerosis and 
endocapillary proliferation were histopathological vari-
ables associated with proteinuria (Working Group of the 
International IgA Nephropathy Network and the Renal 
Pathology Society et al. 2009b). Indeed, a trend towards 
Fig. 2 Serum creatinine (mg/dL) values according to Oxford classification. M mesangial hypercellularity (0 absent; 1 present); E endocapillary 
proliferation (0 absent; 1 present); S segmental sclerosis/adhesions/synechiae (0 absent; 1 present); T tubular atrophy/interstitial fibrosis (0–0–25 %; 
1–26–50 %; 2 to >50 %)
Table 1 Frequency of  chronic tubulointerstitial lesions 
(Oxford T1 and T2) according to glomerular variables
Oxford classification Frequency (%) P (Fisher’s exact test)
M1 E0 S0 T0 11.9 0.84
M1 E0 S0 T ≠ 0 3.8
M0 E1 S0 T0 0.9 0.15
M0 E1 S0 T ≠ 0 0.9
M0 E0 S1 T0 14.8 0.09
M0 E0 S1 T ≠ 0 7.8
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higher 24-h proteinuria levels was observed in patients 
with mesangial hypercellularity (M1) which is similar to 
previous observations in Brazil, South Korea and Sweden 
(Neves et al. 2012; Kang et al. 2012; Halling et al. 2012). 
This series however demonstrated that migration from a 
T0 to a T1 pattern was also associated with proteinuria. 
Increasing extent of interstitial fibrosis and tubular atro-
phy was also a marker of rising serum creatinine levels, 
in keeping with the seminal findings of the Oxford Clas-
sification cohort. These data underline the importance 
of tubulo-interstitial lesions in IgAN as opposed to the 
relative underestimation of this compartment in other 
classification schemes applied to IgAN and to other dis-
eases which overemphasise the importance of glomerular 
pathology. We thus tried to pinpoint which glomerular 
variables were more strongly associated with T1 and T2 
lesions. Only the presence segmental sclerosis, adhesions 
and synechiae (S1 lesions) seem to be somewhat associ-
ated with chronic tubular and interstitial impairment. 
This finding is partly supported by previous reports 
which point out a possible podocytopathic pathway and 
the involvement of multiple glomerular structures in the 
development of focal segmental sclerosis lesions in IgAN. 
These findings alongside our data may support recent 
evidence that suggest that mesangial IgA deposition trig-
gers podocyte lesion and the development of adhesions 
and synechiae which in turn leads to tubulo-interstitial 
injury via podocyte-tubular crosstalk (Menon et al. 2013; 
Wang et al. 2012; Lai 2012; Zhu et al. 2013). These phe-
nomena may yield epithelial-mesenchymal transition and 
consequent interstitial fibrogenesis.
Conclusions
To date this is the largest series of IgAN in this country. 
Demographic data were consistent with previous pub-
lished reports—slight male predominance of patients in 
their 30 s, presenting with hematuria and proteinuria and 
slightly elevated serum creatinine at diagnosis. M1 and 
T1 lesions were more strongly associated with proteinu-
ria. Higher serum creatinine values were identified in 
patients with T1 and T2 lesions. S1 lesions tended to be 
more closely associated with the development of chronic 
tubulo-interstitial injury. Despite its shortcomings—lack 
of full ultrastructural studies for all cases, absence of fol-
low up data and scarce clinical data—this study displays 
a large series of cases stemming from a nationwide data-
base. Further investigation regarding the role of crescents, 
reproducibility of diagnostic criteria and validation of the 
Oxford classification in this country are still pending.
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